NAD+ 800 mg
NAD+ is a coenzyme and nucleotide derivative, not a peptide, that is central to cellular energy production, redox balance, and repair signalling. It is commonly used in metabolic, mitochondrial, and recovery focused settings where cellular resilience, energy turnover, and cognitive support are prioritised. NAD+ is valued for its role in foundational cellular function rather than anabolic, hormonal, or performance driven outcomes.
NAD+ is a coenzyme and nucleotide derivative, not a peptide, that is essential for cellular energy transfer and metabolic regulation. It participates in redox reactions and also serves as a substrate for enzymes involved in DNA repair, stress signalling, and cellular maintenance, including sirtuins and PARPs. It is commonly used in metabolic and recovery focused environments where mitochondrial support, energy balance, and cellular resilience are prioritised.
Properties and Effects
Supports cellular energy metabolism
Supports mitochondrial function and redox balance
May support recovery from metabolic stress
Supports DNA repair related signalling pathways
Does not act through hormonal or endocrine pathways
Chemical Structure Model
Mechanism of Action
NAD+ functions as a core electron carrier in oxidation reduction reactions and is required for efficient cellular energy production. It also acts as a consumable substrate for enzymes such as sirtuins, PARPs, and CD38, which are involved in genome maintenance, stress responses, and metabolic regulation. Because of this dual role, NAD+ influences both energy turnover and cellular repair signalling rather than acting like a hormone or growth factor.
Recommended Use
NAD+ is typically used in metabolic, mitochondrial, cognitive, or recovery focused protocols. It may be considered during periods of high physical or mental stress, reduced energy, or increased recovery demand. It is generally used as part of a broader strategy that includes nutrition, hydration, sleep, and overall recovery practices.
Safety and Side Effects
Human evidence for direct NAD+ administration is still limited, but published reviews suggest the field is active and still developing. In one human pilot study, 750 mg intravenous NAD+ was administered over 6 hours without adverse effects being observed, while a newer real world comparison reported that NAD+ IV was associated with moderate to severe symptoms often requiring longer infusion times than NR IV. This suggests tolerability may depend strongly on route and administration speed. NAD+ does not suppress natural testosterone and is not associated with aromatisation because it is a cellular coenzyme rather than an anabolic hormone.
Special Notes
NAD+ is not a steroid, hormone, SARM, or SERM. It is better classified as a metabolic coenzyme or nucleotide derivative. Its role is supportive and regulatory at the cellular level, with emphasis on bioenergetics, repair signalling, and stress adaptation rather than direct muscle building or endocrine manipulation.
Recommended dosage
25 mg (very cautious start) – 6.25 units
50 mg – 12.5 units
100 mg – 25 units
150 mg – 37.5 units
200 mg – 50 units
Timing of doses
1 to 3 times per week
If using 50 mg to 100 mg
Once:
→ Morning (ideal)
If splitting doses
Morning + early afternoon
Sleep Warning
Do not take NAD⁺ within 6 to 8 hours before sleep.
It may increase alertness and disrupt sleep quality.
Practical guidance
NAD+ is generally approached more as a metabolic support compound than a conventional peptide cycle product. Administration protocols vary widely, so conservative use and careful monitoring are sensible. Where used parenterally, slower delivery is typically preferred, especially if tolerability is an issue. Long term outcome data for wellness style use remains limited, so it is better framed as an investigational or supportive compound rather than a guaranteed performance enhancer.
Estimated Degradation
Model classification
Moderate stability, possibly moderate to relatively stable when refrigerated, but clearly less stable once kept in aqueous solution over time.
Evidence strength
Moderate for general solution stability reasoning, weak for exact post reconstitution vial potency under real world handling conditions.
Assumption used
Reconstituted in sterile or bacteriostatic water, stored refrigerated at 2 to 8 degrees Celsius, protected from light, minimal agitation, and not held in alkaline or phosphate rich conditions. Supplier stability documentation states that neutral or slightly acidic NAD+ solutions are stable at 0 degrees Celsius for at least 2 weeks, while heating and alkaline conditions accelerate degradation. A recent stability study also examined NAD+ behaviour in common buffers over time at 19 degrees Celsius and 25 degrees Celsius, supporting the view that solution stability is condition dependent rather than fixed.
Estimated degradation model for NAD+ 800 mg
| Time after mixing | Estimated remaining potency | Estimated degradation |
| 1 week | 97% | 3% |
| 2 weeks | 93% | 7% |
| 3 weeks | 88% | 12% |
| 4 weeks | 82% | 18% |
| 5 weeks | 75% | 25% |
| 6 weeks | 67% | 33% |
Using Peptide Injectable Vials
STEP 1:VERIFY VIAL INTEGRITY
Inspect both the peptide vial and the bacteriostatic water vial carefully. Check that the caps and seals are intact and have not been tampered with. The contents should appear clear, with no visible particles, cloudiness, or contamination before proceeding.
IMPORTANTINSPECT THE LID
Check both the peptide vial and the bacteriostatic water vial. Locate the small arrows stamped into the gold seal, which indicate the correct opening point. The seal should be opened from the side the arrows point to for proper removal.
STEP 2:LIFT PROTECTIVE CAPS
Gently lift the clear plastic protective cap from the top of the vial. This exposes the gold aluminium safety seal underneath. Take care not to bend or damage the metal seal while removing the plastic cap.
STEP 3:BREAK OFF SAFETY TABS
While lifting the plastic cap from the side indicated by the arrows, gently wiggle it left and right until the small metal tear tab snaps. This opens the seal correctly and exposes the rubber stopper without removing the entire aluminium ring.
IMPORTANTMETAL SEAL REMOVED
The gold metal seal should be lifted from the side indicated by the arrows, leaving the rubber stopper clearly visible. The opening should appear clean and unobstructed, with the metal seal removed evenly and without bending into the centre of the vial.
STEP 4:ADD BACTERIOSTATIC WATER
Insert the syringe needle into the bacteriostatic water vial and draw the required amount of liquid. Slowly inject the water into the peptide vial, allowing the liquid to run down the inner wall of the vial to help protect the peptide.
STEP 5:DISSOLVE THE PEPTIDE
Gently roll or spin the vial between your fingers until the peptide is completely dissolved. Do not shake the vial, as vigorous shaking may damage the peptide structure and reduce its stability.
STEP 6:MEASURE REQUIRED DOSE
Insert the syringe into the vial and draw the required dose through the rubber stopper. Store the mixed solution in a refrigerator and use it within 30 days after mixing.
Additional Product Information
| Product Name | NAD+ 800 mg |
|---|---|
| Product Stock Code | VM-NAD-800-1 |
| Categories |  Peptides / Growth Hormones |
| Presentation Size | 800 mg per vial |
| Strength | 800 mg per box |
| Product Container | Peptides |
More Information
Please login to view more
